Christiane von der Eltz becomes new member of the Executive Board of BERLIN-CHEMIE responsible for the Pharma Germany Division

Christiane von der Eltz becomes new member of the Executive Board of BERLIN-CHEMIE responsible for the Pharma Germany Division

  • Christiane von der Eltz has been appointed to the Executive Board of BERLIN-CHEMIE AG as of 1 June 2022 where she will head the company's German business.
     

Berlin, 3 May 2022 – Christiane von der Eltz has been appointed to the Executive Board of BERLIN-CHEMIE as of 1 June 2022, where she will be responsible for the Pharma Germany Division.

"I look forward to working with an excellent team to further advance the pharmaceutical care of patients with innovative medicines in Germany," said Christiane von der Eltz.

Prior to her role at BERLIN-CHEMIE, Christiane von der Eltz was General Manager and Country Speaker of Merck Switzerland. She holds a degree in pharmacy and has many years of experience in the pharmaceutical industry in various therapeutic areas such as general medicine, diabetes, special medicine and oncology.

 "We are delighted that with Christiane von der Eltz we have been able to attract a proven expert with international experience who knows the pharmaceutical business very well," said BERLIN-CHEMIE's Chief Executive Officer, Dr Luca Lastrucci.

 


About BERLIN-CHEMIE / Menarini Group

BERLIN-CHEMIE AG is an international research-based pharmaceutical company based in Berlin, Germany. The company is a subsidiary of the Italian pharmaceutical and diagnostics company Menarini and within the Group responsible for the German, Central and Eastern European and Central Asian markets. In 2021 BERLIN-CHEMIE employed around 5,000 people worldwide and recorded sales of 1.5 billion euro.

The Menarini Group, headquartered in Florence, Italy, is represented in over 140 countries worldwide and generates annual sales of over 3.75 billion euro. For more than 135 years, Menarini has invested in the development and commercial distribution of medicines to offer patients and healthcare professionals around the world a broad portfolio of products in cardiovascular, respiratory, gastroenterology, metabolism, infectious diseases and anti-inflammatory/pain-relieving therapies, among others. Menarini is also heavily involved in the field of oncology.

 

Contact Person

Alessandro Grua
Manager Communications & Public Relations
BERLIN-CHEMIE AG
Glienicker Weg 125
12489 Berlin
Tel.: +49 (0)30 6707 3010
E-Mail: agrua@berlin-chemie.de

LAST NEWS

Further topics